Stocks and Investing Stocks and Investing
Mon, May 20, 2024
Fri, May 17, 2024

Leland Gershell Initiated (CAPR) at Buy and Held Target at $14 on, May 17th, 2024


Published on 2024-10-28 11:28:50 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Initiated "Capricor Therapeutics, Inc." (CAPR) at Buy and Held Target at $14 on, May 17th, 2024.

Leland has made no other calls on CAPR in the last 4 months.



There are 3 other peers that have a rating on CAPR. Out of the 3 peers that are also analyzing CAPR, 0 agree with Leland's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Leland


  • Aydin Huseynov of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $25 on, Tuesday, May 14th, 2024
  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Tuesday, May 14th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $8 on, Tuesday, May 14th, 2024
Contributing Sources